Michael Dydo

Michael Dydo currently serves as Vice President of Clinical Development in Oncology at Syneos Health since June 2021. Prior to this role, Michael held positions as Executive Director and Product Leader in Oncology at Ayala Pharmaceuticals and as Senior Director of Clinical Operations at AnaptysBio. Michael's extensive experience in oncology also includes a tenure at Astellas Pharma as Senior Director of GDPL - Oncology and various leadership roles at Takeda, including Director of Portfolio Management. Michael began their career at Abbott Laboratories as a CRA. Educational credentials include an MBA from the Indiana University Kelley School of Business, a Leadership and Management Certificate from Wharton Online, and a BS in Chiropractic from the National College of Chiropractic.